{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04278898",
            "orgStudyIdInfo": {
                "id": "IRB-54931"
            },
            "secondaryIdInfos": [
                {
                    "id": "1K99HD101702",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/1K99HD101702"
                }
            ],
            "organization": {
                "fullName": "Stanford University",
                "class": "OTHER"
            },
            "briefTitle": "Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Single-dose",
            "officialTitle": "Targeting the Neurobiology of Restricted and Repetitive Behaviors in Children With Autism Using N-acetylcysteine: a Single-dose Challenge Study",
            "therapeuticArea": [
                "Other"
            ],
            "study": "targeting-the-neurobiology-of-rrb-in-autism-using-n-acetylcysteine-single-dose"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-02-12",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-02-18",
            "studyFirstSubmitQcDate": "2020-02-18",
            "studyFirstPostDateStruct": {
                "date": "2020-02-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-23",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "John Patrick Hegarty",
                "investigatorTitle": "Instructor",
                "investigatorAffiliation": "Stanford University"
            },
            "leadSponsor": {
                "name": "Stanford University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this study is to target the neurobiology of restricted and repetitive behaviors in children with autism spectrum disorder using N-acetylcysteine (NAC), a well-tolerated nutritional supplement that has shown promise for reducing symptom severity in recent small-scale trials. The findings from this research will shed light on the mechanisms of action underlying the clinical benefits of NAC."
        },
        "conditionsModule": {
            "conditions": [
                "Autism Spectrum Disorder"
            ],
            "keywords": [
                "Magnetic Resonance Imaging",
                "N-acetylcysteine",
                "Restricted and Repetitive Behaviors",
                "electroencephalography"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 24,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "N-acetylcysteine then Placebo",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: N-Acetylcysteine"
                    ]
                },
                {
                    "label": "Placebo then N-acetylcysteine",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: N-Acetylcysteine"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "N-Acetylcysteine",
                    "description": "N-acetylcysteine Single Dose 2700 mg taken orally",
                    "armGroupLabels": [
                        "N-acetylcysteine then Placebo",
                        "Placebo then N-acetylcysteine"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in glutamatergic neurometabolites (Glx) measured by proton spectroscopy Magnetic Resonance Imaging (MRI)",
                    "timeFrame": "1 hour after single dose"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in Gamma band amplitude and synchronization measured by electroencephalography",
                    "timeFrame": "1 hour after single dose"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* children between 3 years and 12 years 11 months at the time of consent\n* diagnosis of Autism Spectrum Disorder confirmed with the Autism Diagnostic Interview-Revised (ADI-R) and the Autism Diagnostic Observation Schedule-2 (ADOS-2), or Brief Observation of Symptoms of Autism (BOSA), or Childhood Autism Rating Scale- Second Edition (CARS-2).\n* at least moderate Restricted and Repetitive Behaviors severity defined by a Children's Yale-Brown Obsessive Compulsive Scale for children with autism spectrum disorder score \u2265 11,\n* physical development indicative of prepubescence as defined by the criteria for Tanner Stage 1,\n* medically stable,\n* passes MR safety screening (e.g., no metal in the body).\n\nExclusion Criteria:\n\n* presence of known genetic abnormalities associated with Autism Spectrum Disorder (e.g. Fragile X),\n* current or life-time diagnosis of severe psychiatric disorder (e.g., schizophrenia),\n* presence of significant medical problems that would interfere with participation,\n* the inability of at least one caregiver to speak/read English to a sufficient level to complete study requirements and materials,\n* individuals taking antioxidant agents and glutathione prodrugs, or\n* the inability/unwillingness to swallow an agent during the screening visit.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "3 Years",
            "maximumAge": "12 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Brianna Alconcher",
                    "role": "CONTACT",
                    "phone": "(650) 723-7845",
                    "email": "autismresearch@stanford.edu"
                },
                {
                    "name": "John Hegarty, PhD",
                    "role": "CONTACT",
                    "phone": "(650) 723-7845",
                    "email": "hegartyj@stanford.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "John Hegarty, PhD",
                    "affiliation": "Stanford University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Stanford University School of Medicine",
                    "status": "RECRUITING",
                    "city": "Stanford",
                    "state": "California",
                    "zip": "94305",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Brianna Alconcher",
                            "role": "CONTACT",
                            "phone": "650-723-7845",
                            "email": "autismresearch@stanford.edu"
                        },
                        {
                            "name": "Hegarty, PhD",
                            "role": "CONTACT",
                            "phone": "(650) 723-7845",
                            "email": "hegartyj@stanford.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.42411,
                        "lon": -122.16608
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "De-Identified data will be shared with the National Database for Autism Research (NDAR)",
            "timeFrame": "The data will be submitted on January 15th and July 15th each year.",
            "accessCriteria": "Researchers with access to the National Database for Autism Research (NDAR) will be able to obtain the submitted data.",
            "url": "https://nda.nih.gov/contribute/sharing-regimen.html"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001321",
                    "term": "Autistic Disorder"
                },
                {
                    "id": "D000067877",
                    "term": "Autism Spectrum Disorder"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002659",
                    "term": "Child Development Disorders, Pervasive"
                },
                {
                    "id": "D000065886",
                    "term": "Neurodevelopmental Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4623",
                    "name": "Autistic Disorder",
                    "asFound": "Autism",
                    "relevance": "HIGH"
                },
                {
                    "id": "M206",
                    "name": "Autism Spectrum Disorder",
                    "asFound": "Autism Spectrum Disorder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5903",
                    "name": "Child Development Disorders, Pervasive",
                    "relevance": "LOW"
                },
                {
                    "id": "M5902",
                    "name": "Developmental Disabilities",
                    "relevance": "LOW"
                },
                {
                    "id": "M30644",
                    "name": "Neurodevelopmental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000111",
                    "term": "Acetylcysteine"
                },
                {
                    "id": "C000030905",
                    "term": "N-monoacetylcystine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000998",
                    "term": "Antiviral Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                },
                {
                    "id": "D000005100",
                    "term": "Expectorants"
                },
                {
                    "id": "D000019141",
                    "term": "Respiratory System Agents"
                },
                {
                    "id": "D000016166",
                    "term": "Free Radical Scavengers"
                },
                {
                    "id": "D000000975",
                    "term": "Antioxidants"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000020011",
                    "term": "Protective Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000931",
                    "term": "Antidotes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3475",
                    "name": "Acetylcysteine",
                    "asFound": "Macular",
                    "relevance": "HIGH"
                },
                {
                    "id": "M244107",
                    "name": "N-monoacetylcystine",
                    "asFound": "Band",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4314",
                    "name": "Antiviral Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M8243",
                    "name": "Expectorants",
                    "relevance": "LOW"
                },
                {
                    "id": "M21137",
                    "name": "Respiratory System Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4292",
                    "name": "Antioxidants",
                    "relevance": "LOW"
                },
                {
                    "id": "M21869",
                    "name": "Protective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4250",
                    "name": "Antidotes",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}